Timing of cigarette smoking as a risk factor for multiple sclerosis

Por Salzer, Jonatan, Sundström, Peter
Publicado em 2013

Improved working ability in a contemporary MS population compared with a historic non-treated MS population in the same geographic area of Sweden

Por Wickström, Anne, Sundström, Peter, Wickström, Lucas, Dahle, Charlotte, Vrethem, Magnus, Svenningsson, Anders
Publicado no Mult Scler J Exp Transl Clin (2015)

Immunological profile in cerebrospinal fluid of patients with multiple sclerosis after treatment switch to rituximab and compared with healthy controls

Por de Flon, Pierre, Söderström, Lars, Laurell, Katarina, Dring, Ann, Sundström, Peter, Gunnarsson, Martin, Svenningsson, Anders
Publicado no PLoS One (2018)

Monitoring disease activity in multiple sclerosis using serum neurofilament light protein

Por Novakova, Lenka, Zetterberg, Henrik, Sundström, Peter, Axelsson, Markus, Khademi, Mohsen, Gunnarsson, Martin, Malmeström, Clas, Svenningsson, Anders, Olsson, Tomas, Piehl, Fredrik, Blennow, Kaj, Lycke, Jan
Publicado no Neurology (2017)

Rituximab in multiple sclerosis: A retrospective observational study on safety and efficacy

Por Salzer, Jonatan, Svenningsson, Rasmus, Alping, Peter, Novakova, Lenka, Björck, Anna, Fink, Katharina, Islam-Jakobsson, Protik, Malmeström, Clas, Axelsson, Markus, Vågberg, Mattias, Sundström, Peter, Lycke, Jan, Piehl, Fredrik, Svenningsson, Anders
Publicado no Neurology (2016)